Justin Warman is the Operations Manager at Vantage Hemp. He has over a decade of production and quality control experience in the cannabis industry brings a natural passion for science. With a degree in biochemistry and chemistry from Colorado State University, he has applied his knowledge to realize ideas from concept, through process implementation, to final products. Over the years he has developed an expertise in different extraction methods, distillation and analytical methods with keen insight into production optimization. Justin has been active in the development of the cannabis industry across the United States, and has been nationally published for his contributions. He brings to Vantage an extensive tool set for the production of high quality cGMP CBD products.
Director Regulatory Affairs & Quality Assurance
Dr. Daniel Chinnapen
Passionately dedicated to precision and quality, Vantage Hemp consistently delivers high-quality, Active Pharmaceutical Ingredient (API) compliant CBD extracts at an unparalleled scale for the industry.
Kurt has over 12 years Facility Management experience involving activities around production, research and development, and controlled growth space.
Thanks to our world-class facility and a team of experts with pharmaceutical experience, Vantage Hemp has CBD extraction down to a science. Using our innovative approach and meticulous process we’re able to produce premium quality, consistent and trusted hemp extracts for use in exceptional CBD products for the marketplace.
Pure Extracts’ CEO, Ben Nikolaevsky, added, “This Agreement marks our entry into the medical cannabis space which will make a significant revenue contribution starting in Q4 and ramping-up in 2022. Abba’s extensive military and medical customer base along with their popular online portal allows us to quickly and efficiently get our outstanding line of full spectrum oil (FSO) CBD and THC vape products and our blister-packaged gummie products, including our ultra-high potency 100 mg CBD chews, to their patients across Canada.”
VANCOUVER, British Columbia and LOUISEVILLE, Québec, June 24, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts”) a plant-based extraction company, focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, and Canada House Wellness Group (CSE: CHV) (“Canada House”), a fully integrated medical cannabis company (together, the “Companies”), are pleased to announce that they have entered into a medical supply agreement (the “Agreement”). Under the terms of the Agreement, Canada House’s wholly owned subsidiary, Abba Medix Corp. (“Abba”), will purchase Pure Extracts’ full line of concentrate products, including CBD, THC and blended vapes and CBD and THC gummies, for sale to its established medical patient base.
June 24, 2021 09:00 ET | Source: Pure Extracts Technologies Corp. Pure Extracts Technologies Corp.
For further information:
Steven Pearce, Vice-President, Legal, Canada House Wellness Group at 289-980-3584.
Pemberton, British Columbia, CANADA